Drugs@FDA document

SPORANOX Review · NDA 020966 SUPPL-4

Drugs@FDA document · JANSSEN PHARMS · Oct 26, 2001

Key facts

Drug name SPORANOX
Document type Review
Application NDA020966
Submission SUPPL-4
Company JANSSEN PHARMS
Document date Oct 26, 2001
FDA document accessdata.fda.gov

At a glance

  • Efficacy-New Indication Document categories
  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents